2019
DOI: 10.1038/s41467-018-08243-1
|View full text |Cite
|
Sign up to set email alerts
|

AAV2.7m8 is a powerful viral vector for inner ear gene therapy

Abstract: Adeno-associated virus (AAV) has been successfully used to deliver gene therapy to improve auditory function in mouse models of hereditary hearing loss. Many forms of hereditary hearing loss have mutations which affect the cochlear hair cells, the mechanosensory cells which allow for sound detection and processing. While most conventional AAVs infect inner hair cells (IHCs) with various efficiencies, they infect outer hair cells (OHCs) and supporting cells at lower levels in the cochlea. Here we examine the in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
78
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(87 citation statements)
references
References 28 publications
(33 reference statements)
4
78
2
Order By: Relevance
“…However, the precise time frame between the onset of Emx2 expression driven by Gfi1-Cre and reversal of centriole positions remains unclear. To further investigate the time required by Emx2 to alter hair bundle orientation, we ectopically expressed Emx2 in utricular explants using AAV2.7m8 adeno-associated virus, which has been shown to infect cochlear HCs efficiently (Isgrig et al, 2019). We infected CAG:GFP-Centrin2 utricular explants at E13.5 with an AAV2.7m8 adeno-associated viral vector, AAV2.7m8-CAG-Emx2-P2A-tdTomato (AAV-Emx2-tdT), in which both Emx2 and tdTomato transcripts were driven under the universal CAG promoter.…”
Section: Infections With Aav-emx2 Reverse Hair Bundle Orientationmentioning
confidence: 99%
“…However, the precise time frame between the onset of Emx2 expression driven by Gfi1-Cre and reversal of centriole positions remains unclear. To further investigate the time required by Emx2 to alter hair bundle orientation, we ectopically expressed Emx2 in utricular explants using AAV2.7m8 adeno-associated virus, which has been shown to infect cochlear HCs efficiently (Isgrig et al, 2019). We infected CAG:GFP-Centrin2 utricular explants at E13.5 with an AAV2.7m8 adeno-associated viral vector, AAV2.7m8-CAG-Emx2-P2A-tdTomato (AAV-Emx2-tdT), in which both Emx2 and tdTomato transcripts were driven under the universal CAG promoter.…”
Section: Infections With Aav-emx2 Reverse Hair Bundle Orientationmentioning
confidence: 99%
“…The third improvement involves the use of recently reported novel AAVs that have a higher transfection rate. [11][12][13][14]16,69,70 We believe that with these improvements, USMB-mediated cochlear gene transfection via the RWM would become a useful tool that could be translated into human clinical applications.…”
Section: Limitations and Future Improvementsmentioning
confidence: 99%
“…The adeno-associated virus (AAV) is widely used in gene therapy due to its high infection efficiency, low pathogenicity and toxicity, sustained expression of the carried genes, as well as its simple, cheap, and fast production [21][22][23][24]. Several studies have achieved good results by AAV vector-mediated gene therapy using animal models with different mutated genes in several types of cells in cochlea [2,21,[25][26][27][28][29][30].…”
Section: A Brief Gene Therapy History In Auditory Diseasementioning
confidence: 99%